Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept)

References

• Namkoong H, Kurashima A, Morimoto K, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22(6):1116–1117. doi:10.3201/eid2206.151086
   PubMed Web of Science ®Google Scholar
• Morimoto K, Hasegawa N, Izumi K, et al. A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013. Ann Am Thorac Soc. 2017;14(1):49–56. doi:10.1513/AnnalsATS.201607-573OC
   PubMed Web of Science ®Google Scholar
• Asakura T, Funatsu Y, Ishii M, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16:145. doi:10.1186/s12931-015-0304-5
   PubMed Web of Science ®Google Scholar
• Vinnard C, Longworth S, Mezochow A, Patrawalla A, Kreiswirth BN, Hamilton K. Deaths related to nontuberculous mycobacterial infections in the United States, 1999–2014. Ann Am Thorac Soc. 2016;13(11):1951–1955. doi:10.1513/AnnalsATS.201606-474BC
   PubMed Web of Science ®Google Scholar
• Aksamit TR, O’Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry. Chest. 2017;151(5):982–992. doi:10.1016/j.chest.2016.10.055
   PubMed Web of Science ®Google Scholar
• Gao YH, Guan WJ, Liu SX, et al. Aetiology of bronchiectasis in adults: a systematic literature review. Respirology. 2016;21(8):1376–1383. doi:10.1111/resp.12832
   PubMed Web of Science ®Google Scholar
• Amital A, Shitrit D, Adir Y. The lung in rheumatoid arthritis. Presse Med. 2011;40(1 Pt 2):e31–48. doi:10.1016/j.lpm.2010.11.003
   Google Scholar
• Perry E, Eggleton P, De Soyza A, Hutchinson D, Kelly C. Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis. Int J Rheum Dis. 2017;20(12):2003–2011. doi:10.1111/1756-185X.12702
   PubMed Web of Science ®Google Scholar
• Swinson DR, Symmons D, Suresh U, Jones M, Booth J. Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol. 1997;36(6):689–691. doi:10.1093/rheumatology/36.6.689
   PubMedGoogle Scholar
• Winthrop KL, Baxter R, Liu L, et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis. 2013;72(1):37–42. doi:10.1136/annrheumdis-2011-200690
   PubMed Web of Science ®Google Scholar
• Brode SK, Jamieson FB, Ng R, et al. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 2015;70(7):677–682. doi:10.1136/thoraxjnl-2014-206470
   PubMed Web of Science ®Google Scholar
• Yoo JW, Jo KW, Kang BH, et al. Mycobacterial diseases developed during anti-tumour necrosis factor-alpha therapy. Eur Respir J. 2014;44(5):1289–1295. doi:10.1183/09031936.00063514
   PubMed Web of Science ®Google Scholar
• Tokuda H, Harigai M, Kameda H, et al. Consensus statements for medical practice: biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]. Respir Investig. 2017;55(3):229–251. doi:10.1016/j.resinv.2017.01.002
   PubMed Web of Science ®Google Scholar
• Aksamit TR, Philley JV, Griffith DE. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respir Med. 2014;108(3):417–425. doi:10.1016/j.rmed.2013.09.014
   PubMed Web of Science ®Google Scholar
• Asakura T, Kimizuka Y, Nishimura T, et al. Serum Krebs von den Lungen-6 level in the disease progression and treatment of Mycobacterium avium complex lung disease. Respirology. 2021;26(1):112–119. doi:10.1111/resp.13886
   Web of Science ®Google Scholar
• Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002;165(3):378–381. doi:10.1164/ajrccm.165.3.2107134
   PubMed Web of Science ®Google Scholar
• Morimoto K, Namkoong H, Hasegawa N, et al. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: analysis of 102 Consecutive Cases. Ann Am Thorac Soc. 2016;13(11):1904–1911. doi:10.1513/AnnalsATS.201604-246OC
   PubMed Web of Science ®Google Scholar
• Yagi K, Ito A, Fujiwara K, et al. Clinical features and prognosis of nontuberculous mycobacterial pleuritis: a Multicenter Retrospective Study. Ann Am Thorac Soc. 2021;18(9):1490–1497. doi:10.1513/AnnalsATS.202008-938OC
   Web of Science ®Google Scholar
• Szymanski EP, Leung JM, Fowler CJ, et al. Pulmonary nontuberculous mycobacterial infection. a multisystem, multigenic disease. Am J Respir Crit Care Med. 2015;192(5):618–628. doi:10.1164/rccm.201502-0387OC
   PubMed Web of Science ®Google Scholar
• Asano S, Mizuno S, Okachi S, et al. Antineutrophil cytoplasmic antibody-associated vasculitis superimposed on infection-related glomerulonephritis secondary to pulmonary mycobacterium avium complex infection. Intern Med. 2016;55(17):2439–2445. doi:10.2169/internalmedicine.55.6588
   Web of Science ®Google Scholar
• Addy C, Doran G, Jones AL, Wright G, Caskey S, Downey DG. Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report. BMC Pulm Med. 2018;18(1):170. doi:10.1186/s12890-018-0732-3
   Web of Science ®Google Scholar
• Ishiguro T, Takayanagi N, Takaku Y, et al. Allergic bronchopulmonary aspergillosis with repeated isolation of nontuberculous mycobacteria. Intern Med. 2013;52(15):1721–1726. doi:10.2169/internalmedicine.52.9537
   PubMed Web of Science ®Google Scholar
• Mohd Noor N, Mohd Shahrir MS, Shahid MS, Abdul Manap R, Shahizon Azura AM, Azhar Shah S. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis. 2009;12(2):136–144. doi:10.1111/j.1756-185X.2009.01376.x
   Web of Science ®Google Scholar
• Willis VC, Demoruelle MK, Derber LA, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 2013;65(10):2545–2554. doi:10.1002/art.38066
   PubMed Web of Science ®Google Scholar
• Quirke AM, Perry E, Cartwright A, et al. Bronchiectasis is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis. Arthritis Rheumatol. 2015;67(9):2335–2342. doi:10.1002/art.39226
   PubMed Web of Science ®Google Scholar
• Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012;345:e5244. doi:10.1136/bmj.e5244
   Web of Science ®Google Scholar
• Perry E, Stenton C, Kelly C, Eggleton P, Hutchinson D, De Soyza A. RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients. Eur Respir J. 2014;44(4):1082–1085. doi:10.1183/09031936.00064014
   Web of Science ®Google Scholar
• Greinert U, Schlaak M, Rusch-Gerdes S, Flad HD, Ernst M. Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria. J Clin Immunol. 2000;20(6):445–452. doi:10.1023/A:1026407815946
   Web of Science ®Google Scholar
• Mori S, Koga Y, Nakamura K, et al. Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: a retrospective cohort study. PLoS One. 2020;15(12):e0243110. doi:10.1371/journal.pone.0243110
   Web of Science ®Google Scholar
• Winthrop KL, Iseman M. Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy. Nat Rev Rheumatol. 2013;9(9):524–531. doi:10.1038/nrrheum.2013.82
   PubMed Web of Science ®Google Scholar
• Gono T. Overview: clinical Significance of Lung Disease Associated with Rheumatoid Arthritis. In: Lung Disease Associated with Rheumatoid Arthritis. Springer Nature Singapore Pte Ltd; 2018.
   Google Scholar
• Nakahara H, Kamide Y, Hamano Y, et al. A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment. Mod Rheumatol. 2011;21(6):655–659. doi:10.3109/s10165-011-0448-1
   PubMed Web of Science ®Google Scholar
• Namkoong H, Tasaka S, Akiyama M, et al. Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report. BMC Pulm Med. 2015;15:126. doi:10.1186/s12890-015-0130-z
   Web of Science ®Google Scholar
• Mori S, Sugimoto M. Is continuation of anti-tumor necrosis factor-alpha therapy a safe option for patients who have developed pulmonary mycobacterial infection?: case presentation and literature review. Clin Rheumatol. 2012;31(2):203–210. doi:10.1007/s10067-011-1902-3
   Web of Science ®Google Scholar
• Mori S, Tokuda H, Sakai F, et al. Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan. Mod Rheumatol. 2012;22(5):727–737. doi:10.3109/s10165-011-0577-6
   PubMed Web of Science ®Google Scholar
• Takei H, Nishina N, Namkoong H, et al. Rheumatoid Arthritis with Nontuberculous Mycobacterial Pulmonary Disease: a Retrospective, Single-center Cohort Study. Modern Rheumatol. 2021. doi:10.1093/mr/roab032
   Web of Science ®Google Scholar